Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Britain's Rolls-Royce raises 2 billion pounds with rights issue

Published 11/12/2020, 02:43 AM
Updated 11/12/2020, 08:15 AM
© Reuters. Workers apply a Rolls Royce decal to the engine of a Bombardier Global 6500 business jet at the Bombardier booth at the National Business Aviation Association (NBAA) exhibition in Las Vegas

LONDON (Reuters) - British engineering company Rolls-Royce (OTC:RYCEY) raised 2 billion pounds ($2.6 billion) from a rights issue on Thursday to bolster its pandemic-hit finances, after shareholders signed up for 94% of the new shares and the rest were sold via a rump placing.

Airlines pay Rolls-Royce based on how many hours its engines fly, so the company's finances have come under increasing pressure after COVID-19 stopped travel earlier this year.

The equity raise unlocks new debt options for the company including 2 billion pounds from a bond issued in October and a bank loan worth 1 billion pounds, as part of a total 5 billion pound liquidity package.

The overwhelming majority of shareholders backed the equity raise, but the results showed there were some dissenters to the issue from what is one of Britain's best known industrial names, with 6% of the new shares issued not initially taken up.

The company said in a statement that 10 underwriting banks including Citigroup (NYSE:C), Goldman Sachs (NYSE:GS) and Morgan Stanley (NYSE:MS) had successfully procured subscribers for the rest of the shares.

Chief Executive Warren East Rolls-Royce can ride out COVID-19 with the new liquidity package and by cutting 1.3 billion pounds in costs, axing 9,000 jobs and closing factories to adjust to lower demand from airline customers that fly with the firm's engines on Boeing (NYSE:BA) 787s and Airbus 350s.

Shares in the company traded down 8% at 90 pence at 1240 GMT. In the rump placing, the new shares were sold at a price of 90 pence per share, the company said.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The stock has had a rollercoaster week. Boosted by news of a vaccine, the shares rocketed by over 90% at one stage on Monday, but closed down 10% on Wednesday. They have lost 61% of their value in the year to date.

Latest comments

.*report
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.